The amniotic membrane as a source of stem cells

Histology and Histopathology

Volumn 25, Issue 1, 2010, Pages 91-98

  Insausti, Carmen L ^a   Blanquer, Miguel ^a   Bleda, Patricia ^a   Iniesta, Paqui ^a   Majado, María J ^a   Castellanos, Gregorio ^a   Moraleda, José M ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

Amnion; Amniotic epithelial stem cell; Amniotic mesenchymal stem cell; Differentiation; Stem cell

Indexed keywords

ADULT; AMNION; ANIMAL; CYTOLOGY; EPITHELIUM CELL; FEMALE; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL; PHYSIOLOGY; PLACENTA; PREGNANCY; REVIEW; STEM CELL; STROMA CELL;

ADULT; AMNION; ANIMALS; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELLS; PLACENTA; PREGNANCY; STEM CELLS; STROMAL CELLS;

EID: 74749097759     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Alviano F., Fossati V., Marchionni C., Arpinati M., Bonsi L., Franchina M., Lanzoni G., Cantoni S., Cavallini C., Bianchi F., Tazzari P.L., Pasquinelli G., Foroni L., Ventura C., Grossi A. and Bagnara GP. (2007). Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro. BMC Dev. Biol. 7, 11-14.
2. Akle C.A., Adinolfi M., Welsh K., Leibowitz L. and McColl I. (1981). Immunogenicity of human amniotic epithelial cells after transplantation into volunteers. Lancet 2, 1003-1005.
3. Bifari F., Lisi V., Miniola E., Pasini A. and Krampera M. (2008). Immune modulation by Mesenchymal Stem Cell. Transfus. Med. Hemother. 35, 194-204.
4. Changdong L., Weiyuan Z. and Xiaoxia J. (2007) Human -placentaderived mesenchymal stem cells inhibit proliferation and function of allogenic immune cell. Cell. Tissue Res. 330, 437-446.
5. Copelan E.A. (2006). Hematopoietic Stem-Cell transplantation. (2006). N. Engl. J. Med. 354, 1813-26.
6. Dazzi F. and Marelli-Berg F. (2008). Mesenchymal stem cells for graftversus-host disease: Close encounters with T cells. Eur. J. Immunol. 38, 1479-1482.
7. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbanch I., Marini F.C., Krause D.S., Deans R., Keating A., Prockop D. and Horwitz E. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315-317.
8. Elwan M.A. and Sakuragawa N. (1997). Evidence for synthesis and release of catecholamines by human amniotic epithelial cells. Neuroreport 8, 3435-3438.
9. Frank H.G. and Kaufman P. (2006). Nonvillous Parts and Trophoblast Invasion. In: Pathology of the human placenta. 5th ed. Benirschke K., Kaufman P. and Baerg R.N. (eds). Springer Berlag. New York. pp 191-287.
10. Herzog E., Chai L. and Krause D.S. (2003). Plasticity of marrow derived stem cells. Blood 102, 3483-3493.
11. Horwitz E.M., Gordon P.L., Koo W.K., Marx J.C., Neel M.D., McNall R.Y. Muul L. and Hofmann T. (2002). Isolated allogenic bone marrow-derived mesenchymal cell engraft and stimulate growth in children with imperfect osteogenesis: Implications for cell therapy of bone. Proc. Natl. Acad. Sci. USA 99, 8932-8937.
12. Horwitz E., Le Blanc K., Dominici M. and Mueller I. (2005). Clarification of the nomenclature for MSC: the Internacional Society for Cellular Therapy position statement. Cytotherapy 7, 393-395.
13. Hunt J.S., Petroff M.G., McIntire R.H. and Ober C. (2005). HLA-G and immune tolerance in pregnancy. FASEB J. 19, 681-693.
14. In't Anker P., Scherjon S., Kleijburg-van der Keur C., Groot-Swings G., Claas F., Fibb W. and Kanhai H. (2004). Isolation of Mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 22, 1338-1345.
15. Jones S., Horwood N., Cope A. and Dazzi F. (2007). The antiproliferative effect of mesenchymal stem cell is a fundamental property shared by all stromal cells. J. Immunol. 179, 2824-2831.
16. Kakishita K., Elwan M.A., Nakao N., Itakura T. and Sakurawaga N. (2000). Human Amniotic epithelial cells produce dopamine and survive after implantation into the striatum of a rat model of Parkinson's disease: a potential source of donor for transplantation therapy. Exp. Neurol. 165, 27-34.
17. Koc O., Day J., Nieder M., Gerson S.L. and Lazarus H.M. and Krivit W. (2002). Allogenic mesenchymal stem cell infusion for treatment of metachromatic leucodystrophy (MLD) and Hurler Syndrome (MPSIH). Bone Marrow Transplant 30, 215-222.
18. Kosuga M., Takahashi S., Sasaki K., Enosawa S., Li X.K., Okuyama S., Fujino M., Suzuki S., Yamada M., Matsuo N., Sakuragawa N. and Okuyama T. (2000). Phenotype correction in murine mucopolysaccharidosis type VII by transplantation of human amniotic epithelial cells after adenovirus-mediated gene transfer. Cell Transplant. 9, 687-692.
19. H., Niederkorn J.Y., Neelam S., Mayhew E., Word R.A., McCulley J.P. and Alizadeh H. (2005). Immunosuppressive factors secreted by human amniotic epithelial cells. Invest. Ophthalmol. Vis. Sci. 46, 900-907.
20. Miki T., Lehmann T., Cai H., Stolz D. and Strom S. (2005). Stem cell characteristics of amniotic epithelial cells. Stem Cells 23, 1549-1559.
21. Miki T. and Strom S.C. (2006). Amnion-derived pluripotent / multipotent stem cells. Stem Cell Rev. 2, 133-142.
22. Miki T., Marongiu F., Ellis E. and Strom S. (2007). Isolation of amniotic epithelial stem cells. Curr. Protoc. Stem Cell Biol. 3, 1E.3.1-1E.3.9
23. Moraleda J.M., Blanquer M., Bleda P., Iniesta P., Ruiz F., Bonilla S., Cabanes C., Tabares L. and Martínez S. (2006). Adult stem cell therapy: Dream or reality? Transplant Immunol. 17, 74-77.
24. Parolini O. and Soncini M. (2006). Human placenta: a source of progenitor/Stem Cells? J. Reprod. Med. Endocrinol. 3, 117-126.
25. Parolini O., Alviano F., Bagnara G., Bilic G., Bühring H., Evangelista M., Hennerbichler S., Liu B., Magatti M., Mao N., Miki T., Maronquiu F., Nakajima H., Nikaido T. Portmann-Lanz C.B., Sankar V., Soncini M., Stadler G., Surbek D., Takahashi T.A., Redl H., Sakuragawa N., Wolbank S., Zeisberger S., Zisch A. and Strom S.C. (2008). Concise Review: Isolation and characterization of cells from human term placenta: Outcome of the First International Workshop on Placenta Derived Stem Cells. Stem Cells 26, 300-311.
26. Portmann-Lanz C.B., Schoeberlein A., Huber A., Sager R., Malek A., Holzgreve W. and Surbek D.V. (2006). Placental mesenchymal stem cells as potential autologous graft for pre - and perinatal neuroregeneration. Am. J. Obstet. Gynecol. 194, 664-673.
27. Rasmusson I. (2006). Immune modulation by mesenchymal stem cells. Exp. Cell. Res. 312, 2169-2179.
28. Reyes M., Lund T., Lenvik L., Aguiar D., Koodie L. and Verfaillie C. (2001). Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 98, 2615-2625.
29. Sakuragawa N., Enosawa S., Ishii T., Thangavel R., Tashiro T., Okuyama T. and Suzuki S. (2000) Human amniotic epithelial cells are promising transgene carriers for allogeneic cell transplantation into liver. J. Hum. Genet. 45, 171-176.
30. Schwartz R., Reyes M., Koodie L., Jiang Y., Blackstad M., Lund T, Lenvik T., Johnson S., Hu W.W. and Verfaillie C.M. (2002). Multipotent adult progenitor cell from bone marrow differentiates into functional hepatocyte-like cells. J. Clin. Invest. 109, 1291-1302.
31. Smith S., Neaves W., Teitelbaum S. (2006). Adult stem cell treatments for disease? Science 313, 439-445.
32. Steigman S.A. and Fauza D.O. (2007). Isolation of Mesenchymal Stem cells from amniotic fluid and placenta. Curr. Protoc. Stem Cell Biol. 1, 1E.2.1-1E.2.12. 33.
33. Stenderup K., Justesen J., Clausen C. and Kaseem-Bone M. (2003). Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cell. Bone 33, 919-926.
34. Tamagawa T., Ishiwata I. and Saito S. (2004). Establishment and characterization of a pluripotent stem cell line derived from human amniotic membranes and initiation of germ layers in vitro. Hum. Cell. 17, 125-130.
35. Wei J.P., Zhang T.S., Kawa S., Aizawa T., Ota M., Akaike T, Kato K., Konishi I. and Nikaido T. (2003). Human amnion-isolated cells normalize blood glucose in streptozotocin-induced diabetic mice. Cell Transplant. 12:545-552.